ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 164 filers reported holding ACCELERON PHARMA INC in Q4 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,851,000 | -17.0% | 13,650 | -21.7% | 0.00% | -20.0% |
| Q4 2020 | $2,231,000 | -54.2% | 17,435 | -59.7% | 0.01% | -54.5% |
| Q3 2020 | $4,869,000 | +3.1% | 43,270 | -12.7% | 0.01% | -8.3% |
| Q2 2020 | $4,721,000 | -17.2% | 49,551 | -21.9% | 0.01% | -29.4% |
| Q1 2020 | $5,699,000 | +2066.9% | 63,415 | +1023.2% | 0.02% | +1600.0% |
| Q1 2019 | $263,000 | -93.6% | 5,646 | -94.0% | 0.00% | -90.9% |
| Q4 2018 | $4,088,000 | -62.2% | 93,870 | -50.4% | 0.01% | -56.0% |
| Q3 2018 | $10,828,000 | +4337.7% | 189,205 | +3663.8% | 0.02% | +2400.0% |
| Q2 2018 | $244,000 | -95.4% | 5,027 | -96.3% | 0.00% | -93.3% |
| Q1 2018 | $5,274,000 | – | 134,893 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,103,937 | $53,563,000 | 5.39% |
| GREAT POINT PARTNERS LLC | 758,000 | $36,778,000 | 5.10% |
| Foresite Capital Management II, LLC | 244,756 | $11,876,000 | 4.18% |
| GREAT POINT PARTNERS LLC | 552,300 | $26,798,000 | 3.71% |
| Foresite Capital Management III, LLC | 278,753 | $13,525,000 | 2.91% |
| QVT Financial LP | 190,977 | $9,266,000 | 2.66% |
| Perceptive Advisors | 1,528,205 | $74,149,000 | 1.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,800 | $54,672,000 | 1.92% |
| SECTORAL ASSET MANAGEMENT INC | 306,626 | $14,877,000 | 1.66% |
| Parametrica Management Ltd | 5,645 | $274,000 | 1.30% |